Prognostic relevance of oncological serum biomarkers in liver cancer patients undergoing transarterial chemoembolization therapy.
about
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something NewC-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic ReviewCirculating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insightsMental status changes postchemoembolization: the role of inflammatory responseReprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospectsThe role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management.Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma conforming to the Milan criteria: systemic review and meta-analysisThe Prognostic Value of Alpha-Fetoprotein Response for Advanced-Stage Hepatocellular Carcinoma Treated with Sorafenib Combined with Transarterial Chemoembolization.The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib.Prognostic role of C-reactive protein in hepatocellular carcinoma: a systematic review and meta-analysis.Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring.The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical managementCirculating markers for prognosis of hepatocellular carcinoma.Decreased FOXF1 promotes hepatocellular carcinoma tumorigenesis, invasion, and stemness and is associated with poor clinical outcome.Experience from a real-life cohort: outcome of 606 patients with hepatocellular carcinoma following transarterial chemoembolization.Predictive Factors for Complete Response and Recurrence after Transarterial Chemoembolization in Hepatocellular Carcinoma.Prognostic value of serum γ-glutamyl transferase in unresectable hepatocellular carcinoma patients treated with transcatheter arterial chemoembolization combined with conformal radiotherapy.Predictive value of immunogenic cell death biomarkers HMGB1, sRAGE, and DNase in liver cancer patients receiving transarterial chemoembolization therapy.KIAA0101 mRNA overexpression in peripheral blood mononuclear cells acts as predictive marker for hepatic cancer.Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization.Transarterial chemoembolization versus sorafenib in patients with hepatocellular carcinoma and extrahepatic disease.Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line
P2860
Q26744542-7FA1FC1A-F159-4F8B-A802-308361828A4EQ26771557-EABA65B5-2B09-42D1-99AE-363C9165938AQ26799928-89F4B382-2D52-4D6A-B837-05C270A3469EQ26996820-BA742010-D5AD-4D9C-B01B-9ACA988DC442Q28076454-B13064ED-F0F4-4F50-8D52-14DCBF9A291BQ34213765-76A6DC91-2B40-4AAA-9F25-752D033624F2Q34547772-88EF0FB4-933D-4227-A386-29F49ED7A6F3Q36528048-B3B1B1F9-8A8C-4F37-A730-22517A75086BQ36544310-EEF606EB-EF82-4CED-827F-D56161BD62D8Q36746912-AB432437-82FC-4FFD-9693-07B6150C9EC1Q37534945-68DFC018-5D53-4931-8D5E-F9CF9F112FD1Q37595952-808BB0E6-9E58-45C3-9EDC-76734BE53F60Q38103946-533CE87E-B3A5-4571-8CB1-6FCF912E3608Q39556002-4E1ACD0D-EBD9-4D4B-9F28-70007E0FD68DQ40593373-0BE144F2-A38F-40D1-B6B8-A40BC7847B07Q41765795-AB06FBA7-C290-48A1-814D-77A8D4DAEC5CQ42931002-CBF1AA08-FE31-4222-BB26-1B2F2D878934Q44844478-9D461D2F-2170-4CEC-BB2F-ECB0A0F546CAQ44961071-3A70DFD7-2E18-43B9-BD97-936D813F42F1Q53271003-E55D22A8-0711-42F2-82AF-034DD55A6ED0Q54965293-E9BB7698-C289-412D-BCB9-2FE4D7334463Q58766220-B1D3CB42-AD3A-4FD3-8448-3C0715AECF91
P2860
Prognostic relevance of oncological serum biomarkers in liver cancer patients undergoing transarterial chemoembolization therapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Prognostic relevance of oncolo ...... ial chemoembolization therapy.
@en
Prognostic relevance of oncolo ...... ial chemoembolization therapy.
@nl
type
label
Prognostic relevance of oncolo ...... ial chemoembolization therapy.
@en
Prognostic relevance of oncolo ...... ial chemoembolization therapy.
@nl
prefLabel
Prognostic relevance of oncolo ...... ial chemoembolization therapy.
@en
Prognostic relevance of oncolo ...... ial chemoembolization therapy.
@nl
P2093
P2860
P1433
P1476
Prognostic relevance of oncolo ...... ial chemoembolization therapy.
@en
P2093
Dietrich Jüngst
Dorothea Nagel
Jürgen Durner
Nikolaus Kohles
Petra Stieber
Stefan Holdenrieder
P2860
P2888
P356
10.1007/S13277-011-0237-7
P577
2011-09-20T00:00:00Z